Evaluation of (68)Ga-Radiolabeled Peptides for HER2 PET Imaging

One in eight women will be diagnosed with breast cancer in their lifetime and approximately 25% of those cases will be HER2-positive. Current methods for diagnosing HER2-positive breast cancer involve using IHC and FISH from suspected cancer biopsies to quantify HER2 expression. HER2 PET imaging cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ducharme, Maxwell, Houson, Hailey A., Fernandez, Solana R., Lapi, Suzanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689602/
https://www.ncbi.nlm.nih.gov/pubmed/36359554
http://dx.doi.org/10.3390/diagnostics12112710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689602/
https://www.ncbi.nlm.nih.gov/pubmed/36359554
http://dx.doi.org/10.3390/diagnostics12112710

Ejemplares similares